Pristane-induced arthritis in the rat.

Area of Science:

• Immunology
• Rheumatology
• Animal Models

Background:

• Pristane-induced arthritis (PIA) is a rat model for chronic relapsing inflammatory arthritis.
• It is induced by a single subcutaneous injection of pristane.

Purpose of the Study:

• To characterize the pristane-induced arthritis (PIA) rat model.
• To identify key pathological and clinical features of PIA.
• To explore diagnostic biomarkers for PIA.

Main Methods:

• Induction of arthritis via pristane injection in rats.
• Clinical assessment using macroscopic scoring.
• Pathological examination of joints.
• Biochemical analysis of plasma biomarkers (e.g., AGP, IL-6, COMP).
• Adoptive transfer studies using CD4+ T-cells.

Main Results:

• PIA onset occurs 2 weeks post-induction, characterized by edema and acute phase response.
• Pathological features include inflammatory cell infiltration, pannus formation, cartilage/bone erosion.
• The disease course involves an acute inflammatory phase followed by relapsing phases with joint deformity.
• PIA is T-cell dependent and transferable via CD4+ T-cells.
• Plasma biomarkers (AGP, IL-6, COMP) correlate with systemic inflammation and cartilage erosion.

Conclusions:

• The PIA rat model effectively recapitulates key features of chronic relapsing inflammatory arthritis.
• PIA is a T-cell mediated autoimmune disease.
• Biochemical markers in plasma can aid in diagnosing and monitoring PIA severity.